This study is currently not recruiting participants.

A Cohort Dose-Escalation Study to Evaluate the Safety of Metrodora Therapeutics? Bovine Lactoferrin (MTbLF) in Patients with Anemia in Crohn's Disease (CD)

  • STATUS
    Not Recruiting
Updated on 19 February 2024

Summary

The purpose of this study is to determine if the safety and the effect of three different doses (strengths) of MTbLF [Metrodora Therapeutics' bovine (comes from a cow) Lactoferrin (a protein found in milk) (abbreviated as MTbLF)] taken with or without food in patients with anemia and Crohn's disease will help them.

Description

The purpose of this study is to determine if the safety and the effect of three different doses (strengths) of MTbLF [Metrodora Therapeutics' bovine (comes from a cow) Lactoferrin (a protein found in milk) (abbreviated as MTbLF)] taken with or without food in patients with anemia and Crohn's disease will help them.

Details
Condition Crohn's disease
Age 100years or below
Clinical Study IdentifierTX6992
Last Modified on19 February 2024

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.